LEADER 01242nas  2200445-a 450 
001 996202494703316
005 20230522213016.0
011   $a2210-7770
035   $a(OCoLC)703452226
035   $a(CKB)2590000000000885
035   $a(CONSER)--2011263012
035   $a(DE-599)ZDB2594323-6
035   $a(EXLCZ)992590000000000885
100   $a20110223a20119999  ---         -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCancer genetics
210   $a[New York, NY] $cElsevier Inc.$dİ2011-
300   $aRefereed/Peer-reviewed
311   $a2210-7762 
531   $aCANCER GENET
531   $aCANCER GENET-NY
606   $aCancer$xGenetic aspects$vPeriodicals
606   $aNeoplasms$xgenetics
606   $aCancer$xGenetic aspects$2fast$3(OCoLC)fst00845368
608   $aPeriodical
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
610   $aOncology
615  0$aCancer$xGenetic aspects
615 12$aNeoplasms$xgenetics
615  7$aCancer$xGenetic aspects.
676   $a616.994042
906   $aJOURNAL
912   $a996202494703316
996   $aCancer genetics$92431577
997   $aUNISA